Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block]

Vesting schedules for the 2009 Plan are as follows:

Vesting Schedule A				Vesting Schedule B				Vesting Schedule C				Vesting Schedule D
	25	%	12 months		33	%	24 months		50	%	48 months		20	%	6 months
	50	%	24 months		67	%	36 months		100	%	57 months		40	%	18 months
	75	%	36 months		100	%	48 months						60	%	30 months
	100	%	48 months										80	%	42 months
													100	%	54 months

Schedule of Share-based Compensation, Activity [Table Text Block]

The following is a summary of the activity in the Company’s stock option plans and other options for the years ended December 31, 2015 and 2014, respectively:

	December 31, 2015				December 31, 2014
			Weighted Avg.				Weighted Avg.
	Shares		Exercise Price		Shares		Exercise Price
Exercisable, beginning of period		132,099	$	5.07		83,718	$	4.67
Vested		34,801		5.65		56,464		5.76
Exercised		29,500		2.88		-		-
Cancelled		(73,000)		6.06		(8,083)		5.77
Exercisable at the end of period		64,400	$	5.26		132,099	$	5.07

	December 31, 2015				December 31, 2014
			Weighted Avg.				Weighted Avg.
	Shares		Exercise Price		Shares		Exercise Price
Outstanding, beginning of period		214,500	$	5.20		228,500	$	5.23
Granted		49,000		5.27		-		-
Exercised		29,500		2.88		-		-
Cancelled		(80,000)		6.01		(14,000)		5.68
Outstanding at the end of period		154,000	$	5.25		214,500	$	5.20

Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding By Grant Date [Table Text Block]

Significant option groups remained outstanding at December 31, 2015 and related weighted average grant date fair value, remaining life and intrinsic value information are as follows:

	Options Outstanding								Options Vested
Options by			Weighted		Remain.		Intrinsic				Weighted		Remain.		Intrinsic
Grant Date	Shares		Avg.		Life		Val		Shares		Avg.		Life		Val
Dec 2005		-		-		-		-		-		-		-		-
Dec 2010		-		-		-		-		-		-		-		-
Jan 2011		6,000		5.96		0.0		-		6,000		5.96		0.0		-
Nov 2012		94,000		5.17		1.9		-		56,400		5.17		1.9		-
Nov 2013		5,000		5.75		2.9		-		2,000		5.75		2.9		-
Dec 2015		49,000		5.27		5.0	$	1,450		-		-		-		-
TOTAL		154,000		5.25		2.9	$	1,450		64,400		5.26		1.8		-

Fair Value, by Balance Sheet Grouping [Table Text Block]

Changes in the fair value of the warrants have been recognized in the consolidated statement of operations.

	December 31,			December 31,			December 31,			December 31,			July 17,
	2015			2014			2013			2012			2012
Weighted average fair value per warrant	$	5.11		$	3.76		$	5.84		$	4.87		$	5.03
Risk-free interest rate		1.76	%		2.47	%		2.45	%		1.18	%		0.99	%
Expected lives		4.0 yrs.			5.0 yrs.			6.0 yrs.			7.0 yrs.			7.5 yrs.
Expected volatility		28.99	%		44.99	%		37.49	%		28.18	%		36.98	%

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

The following is a summary of the activity of the Company’s warrants for the years ended December 2015 and 2014:

	December 31, 2015				December 31, 2014
			Weighted Avg.				Weighted Avg.
	Shares		Exercise Price		Shares		Exercise Price
Outstanding and exercisable, beginning of period		140,048	$	0.01		140,048	$	0.01
Granted		-		-		-		-
Exercised		-		-		-		-
Cancelled		-		-		-		-
Outstanding and exercisable at the end of period		140,048	$	0.01		140,048	$	0.01